We are live on ! Find out more
CAH icon

Cardinal Health

930 hedge funds and large institutions have $17.1B invested in Cardinal Health in 2022 Q4 according to their latest regulatory filings, with 162 funds opening new positions, 291 increasing their positions, 345 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

149% more first-time investments, than exits

New positions opened: 162 | Existing positions closed: 65

25% more call options, than puts

Call options by funds: $228M | Put options by funds: $182M

12% more funds holding in top 10

Funds holding in top 10: 1719 (+2)

10% more funds holding

Funds holding: 849930 (+81)

8% more capital invested

Capital invested by funds: $15.8B → $17.1B (+$1.32B)

1.41% less ownership

Funds ownership: 87.26%85.85% (-1.4%)

16% less repeat investments, than reductions

Existing positions increased: 291 | Existing positions reduced: 345

Holders
930
Holders Change
+81
Holders Change %
+9.54%
% of All Funds
14.95%
Holding in Top 10
19
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+11.76%
% of All Funds
0.31%
New
162
Increased
291
Reduced
345
Closed
65
Calls
$228M
Puts
$182M
Net Calls
+$46M
Net Calls Change
-$70.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.41B -$63.2M -831,365 -3%
BlackRock
2
BlackRock
New York
$2.27B +$62.8M +827,065 +3%
State Street
3
State Street
Massachusetts
$1.35B -$213M -2,799,089 -14%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$616M -$2.12M -27,855 -0.3%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$412M -$5.95M -78,301 -1%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$384M -$244M -3,207,939 -39%
Invesco
7
Invesco
Georgia
$359M -$37.9M -498,304 -10%
Morgan Stanley
8
Morgan Stanley
New York
$353M +$12.3M +161,667 +4%
Amundi
9
Amundi
France
$320M -$102M -1,337,975 -24%
Arrowstreet Capital
10
Arrowstreet Capital
Massachusetts
$298M +$101M +1,327,772 +52%
Northern Trust
11
Northern Trust
Illinois
$256M -$17.9M -235,956 -7%
Norges Bank
12
Norges Bank
Norway
$220M +$20.7M +272,024 +10%
Pzena Investment Management
13
Pzena Investment Management
New York
$196M -$13.9M -183,203 -7%
LSV Asset Management
14
LSV Asset Management
Illinois
$188M -$9.38M -123,500 -5%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$184M -$177M -2,330,040 -49%
ProShare Advisors
16
ProShare Advisors
Maryland
$172M -$43.7M -575,655 -21%
Legal & General Group
17
Legal & General Group
United Kingdom
$171M -$14.1M -184,967 -8%
Pacer Advisors
18
Pacer Advisors
Pennsylvania
$154M +$66.7M +878,429 +78%
EIM
19
Elliott Investment Management
Florida
$154M
Two Sigma Investments
20
Two Sigma Investments
New York
$153M +$41.9M +551,614 +38%
Allianz Asset Management
21
Allianz Asset Management
Germany
$151M -$4.97M -65,421 -3%
UBS AM
22
UBS AM
Illinois
$151M +$17.7M +233,486 +13%
Goldman Sachs
23
Goldman Sachs
New York
$151M +$42.7M +562,270 +40%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$134M +$40.7M +535,889 +45%
Charles Schwab
25
Charles Schwab
California
$130M -$10.1M -133,034 -7%

CAH Hedge Fund Activity: Q4 2022 in Review

930 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q4 2022, worth a combined $17.1B — up 8.4% from $15.8B a quarter earlier.

Buyers outnumbered sellers: 162 funds opened new CAH positions and 65 closed out — a net gain of 97 holders — while 291 added to existing stakes and 345 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $101M. The largest seller was T. Rowe Price Associates, cutting an estimated $244M.

  • 930 institutional investors held Cardinal Health (CAH) as of Q4 2022, up from 849 in Q3 2022.
  • Funds reported $17.1B of Cardinal Health stock for Q4 2022, up 8.4% quarter-over-quarter.
  • 162 funds opened new Cardinal Health positions in Q4 2022 and 65 closed out, a net change of +97 holders.
  • The largest Cardinal Health buyer in Q4 2022 was Arrowstreet Capital, an estimated $101M added.
  • The largest Cardinal Health seller in Q4 2022 was T. Rowe Price Associates, an estimated $244M sold.

Based on aggregated 13F filings for Q4 2022.